MMCS

Ariadne Labs Announces 2022-2023 Spark Grant Recipients

Retrieved on: 
Wednesday, January 11, 2023

BOSTON, Jan. 11, 2023 /PRNewswire/ -- Ariadne Labs today announced five recipients of the Ariadne Labs Spark Grant innovation awards for the 2022-2023 year. The Spark Grant program provides support for new and early-stage ideas focused on making health care safer, more integrated, and more equitable for all patients. Now in its tenth year, the program has funded more than 20 projects. 

Key Points: 
  • Five grants will support early-stage ideas to make health care safer, more integrated, and more equitable
    BOSTON, Jan. 11, 2023 /PRNewswire/ -- Ariadne Labs today announced five recipients of the Ariadne Labs Spark Grant innovation awards for the 2022-2023 year.
  • The Spark Grant program provides support for new and early-stage ideas focused on making health care safer, more integrated, and more equitable for all patients.
  • The 2022-2023 recipients of the Ariadne Labs Spark Grant innovation awards are:
    Rose Molina, MD, MPH, Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School; Obstetrician-Gynecologist at Beth Israel Deaconess Medical Center and The Dimock Center; Core Faculty at Ariadne Labs
    Evidence suggests that individuals with limited English language proficiency experience lower quality maternal health care due to structural barriers and communication challenges.
  • In 2021 a Spark Grant funded initial work to develop a checklist to triage potential candidates for EVT.

Morphic Announces Initiation of EMERALD-2 Phase 2b Clinical Trial of MORF-057 in Patients with Moderate-to-Severe Ulcerative Colitis

Retrieved on: 
Tuesday, November 22, 2022

EMERALD-2 (MORF-057-202) is a global phase 2b randomized, double-blind, placebo-controlled trial of MORF-057 in patients with moderate-to-severe ulcerative colitis.

Key Points: 
  • EMERALD-2 (MORF-057-202) is a global phase 2b randomized, double-blind, placebo-controlled trial of MORF-057 in patients with moderate-to-severe ulcerative colitis.
  • The primary endpoint of EMERALD-2 is clinical remission rate as measured by the Modified Mayo Clinic Score (mMCS) at 12 weeks.
  • Following the 12-week induction phase, all patients will receive MORF-057 for 40 weeks of maintenance dosing.
  • Morphic is developing MORF-057 as a selective, oral small molecule inhibitor of the 47 integrin for patients with inflammatory bowel disease (IBD).

Aircraft Insulation Market - Global Forecast to 2026: Increase in Demand for Composite Materials from General Aviation (Ga) and Business Jets Industry to Reduce Cabin Noise - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 16, 2021

Increase in demand for lightweight insulation materials is a key factor that is expected to drive the aircraft insulation market.

Key Points: 
  • Increase in demand for lightweight insulation materials is a key factor that is expected to drive the aircraft insulation market.
  • Such advancements in the aircraft insulation technology are expected to lead to their demand during the forecast period.
  • The acoustic & vibration insulation is projected to dominate the aircraft insulation market during the forecast period.
  • North America is projected to be the largest regional share of the global aircraft insulation market during the forecast period.

Metal Matrix Composite Global Market Report 2021: Focus on Aluminium, Magnesium, Copper, Super Alloys MMCs - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 31, 2021

The "Metal Matrix Composite Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Metal Matrix Composite Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
  • Metal Matrix Composite Global Market Report 2021 provides the strategists, marketers and senior management with the critical information they need to assess the global metal matrix composite market.
  • The metal matrix composite market consists of sales metal matrix composites by entities (organizations, sole traders, and partnerships) that manufacture metal matrix composite materials.
  • Global Metal Matrix Composite Market, Segmentation by Matrix Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion